High Dose Sequential Therapy and Autologous Stem Cell Rescue for Multiple Myeloma

Not Recruiting

Trial ID: NCT00186238

Purpose

To assess the role of autologous hematopoietic cell rescue in the treatment of multiple myeloma.

Official Title

High Dose Sequential Therapy and Autologous Stem Cell Rescue for Multiple Myeloma

Stanford Investigator(s)

Sally Arai
Sally Arai

Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)

Laura Johnston
Laura Johnston

Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)

Robert Negrin
Robert Negrin

Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)

Eligibility

Inclusion Criteria:- received cytoreduction prior to transplant

* adequate organ function Exclusion Criteria:- previous transplant
* smoldering MM or benign monoclonal gammopathy

Intervention(s):

procedure: high dose chemotherapy then autologous hematopoietic cell transplant

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
BMT Referrals
6507230822

New Trial Alerts